Your firm must have an account to access this feature
U.S. Securities and Exchange Commission v. C3 International, Inc. et al
Case Number:
8:21-cv-01586
Court:
Nature of Suit:
Judge:
Companies
Government Agencies
Sectors & Industries:
-
September 16, 2024
Pot Co. Execs Go To 9th Circ. In Investment Scam Case
A California cannabis company and its co-founders on Monday appealed a federal court decision booting them from the securities industry and holding them liable for roughly $6 million tied to a medical marijuana investment scam, the same day that the U.S. Securities and Exchange Commission asked the court to order a third individual to pay up for his part in the alleged scam.
-
April 21, 2023
SEC Wants Pot Pill Co., Promoter's Fraud Suits Consolidated
The U.S. Securities and Exchange Commission asked a California federal judge Friday to consolidate enforcement actions against C3 International, maker of the cannabis pill Idrasil, and a former business development chief stemming from alleged fraudulent securities offerings.
-
November 10, 2022
Pot Pill Co. Ordered To Pay $5M In SEC Fraud Suit
A California federal judge has granted a default judgment against the makers of cannabis pill Idrasil in a suit from the U.S. Securities and Exchange Commission alleging it defrauded investors, ordering the company to pay $1.9 million in disgorgement and $3.1 million in civil penalties.
-
September 28, 2021
SEC Says Cannabis Pill Maker Ran $2M Securities Fraud
The U.S. Securities and Exchange Commission on Tuesday filed suit against the makers of the cannabis pill Idrasil, alleging that C3 International Inc. and its co-founders raised approximately $2 million from more than 40 investors by selling stock in the company through misrepresentations, omissions and false statements.